References
- Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. Metabolic basis of inherited disease. 8th ed. New York: McGraw-Hill, 2001:3421-52.
- van de Kamp JJP, Niemeijer MF, von Figura K, Giesberts MAH. Genetic heterogeneity and clinical variability in Sanfilippo Syndrome (Types A, B and C). Clin Genet 1981;20:152-60.
- Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA 1999;281:249-254. https://doi.org/10.1001/jama.281.3.249
- Lowry RB, Applegarth DA, Toone JR, MacDonald E, Thunem NY. An update on the frequency of mucopolysaccharide syndromes in British Columbia. Hum Genet 1990;85:389-90.
- Michelakakis H, Dimitriou E, Tsagaraki S, Giouroukos S, Schulpis K, Bartsocas. Lysosomal storage diseases in Greece. Genet Couns 1995;6:43-7.
- Betris NG, Sklower SL, Wilbur L, Matalon R. Sanfilippo disease in Greece. Clin Genet 1986;29:129-32.
- Cleary MA, Wraith JE. Management of mucopolysaccharidosis type III. Arch Dis Child 1993;69:403-6. https://doi.org/10.1136/adc.69.3.403
- Bhattacharyya R, Gliddon B, Beccari T, Hopwood JJ, Stanley P. A novel missense mutation in lysosomal sulfamidase is the basis of MPS III A in a spontaneous mouse mutant. Glycobiology 2001;11:99-103. https://doi.org/10.1093/glycob/11.1.99
- Crawley A, Gliddon BL, Auclair D, Brodie SL, Hirte C, King BM, et al. Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA. Brain Res 2006;1104:1-17. https://doi.org/10.1016/j.brainres.2006.05.079
- Bhaumik M, Muller VJ, Rozaklis T, Johnson L, Dobrenis K, Bhattacharyya R, et al. A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome). Glycobiology 1999;9:1389-96. https://doi.org/10.1093/glycob/9.12.1389
- Hemsley K, Luck AJ, Crawley AC, Hassiotis S, Beard H, King B, et al. Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease. Eur J Neurosci 2009;29:1197-214. https://doi.org/10.1111/j.1460-9568.2009.06666.x
- Li H, Yu WH, Rozengurt N, Zhao HZ, Lyons KM, Anagnostaras S, et al. Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc Natl Acad Sci USA 1999;96:14505-10. https://doi.org/10.1073/pnas.96.25.14505
- Todd D. DT, Colleen E. Mood and Anxiety Related Phenotypes in Mice of the series Neuromethods, vol. 42; 2009.
-
Sarter M, Bodewitz G, Stephens DN. Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and antagonist
${\beta}$ -carboline. Psychopharmacology 1988;94:491-5. https://doi.org/10.1007/BF00212843 - Kwon Y, Vinayagam A, Sun X, Dephoure N, Gygi SP, Hong P, Perrimon N. The Hippo signaling pathway interactome. Science 2013;8:737-40.
- Olton DS. Mazes, maps, and memory. Am Psychol 1979;34:583-96. https://doi.org/10.1037/0003-066X.34.7.583
- Maren S. Neurobiology of Pavlovian fear conditioning. Annu Rev Neurosci 2001;24:897-931. https://doi.org/10.1146/annurev.neuro.24.1.897
- Fan Z, Styner M, Muenzer J, Poe M, Escolar M. Correlation of automated volumetric analysis of brain MR imaging with cognitive impairment in a natural history study of mucopolysaccharidosis II. Am J Neuroradiol 2010;31:1319-23. https://doi.org/10.3174/ajnr.A2032
- Vogler C, Levy B, Galvin N, Lessard M, Soper B, Barker J. Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse. Pediatr Dev Pathol 2005;8:453-62. https://doi.org/10.1007/s10024-005-0025-8
- Hemsley KM, Hopwood JJ. Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA(MPS-IIIA). Behav Brain Res 2005;158:191-9. https://doi.org/10.1016/j.bbr.2004.08.019
- Malinowska M, Wilkinson FL, Bennett W, Langford-Smith KJ, O'Leary HA, Jakobkiewicz-Banecka J, et al. Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice. Mol Genet Metab 2009;98:235-42. https://doi.org/10.1016/j.ymgme.2009.06.013
- Fu H, Kang L, Jennings JS, Moy SS, Perez A, Dirosario J, et al. Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice. Gene Ther 2007;14:1065-77. https://doi.org/10.1038/sj.gt.3302961
- Cressant A, Desmaris N, Verot L, Brejot T, Froissart R, Vanier MT, et al. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adenoassociated virus-mediated gene transfer in the striatum. J Neurosci 2004;24:10229-39. https://doi.org/10.1523/JNEUROSCI.3558-04.2004
- Gliddon BL, Hopwood JJ. Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice. Pediatr Res 2004;56:65-72. https://doi.org/10.1203/01.PDR.0000129661.40499.12
- Savas PS, Hemsley KM, Hopwood JJ. Intracerebral injection of sulfamidase delays neuropathology in murine MPS-IIIA. Mol Genet Metab 2004;82:273-85. https://doi.org/10.1016/j.ymgme.2004.05.005
- Small DH, Mok SS, Williamson TG, Nurcombe V. Role of proteoglycans in neural development, regeneration and the aging brain. J Neurochem 1996;67:889-99.